DXA scanning in women over 50 years with distal forearm fracture shows osteoporosis is infrequent until age 65 years

International Journal of Clinical Practice

Volumn 62, Issue 3, 2008, Pages 388-393

  Lashin, H ^a   Davie, M W J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID DERIVATIVE; HORMONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOREARM FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; FOREARM INJURIES; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS;

EID: 38849108054     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01395.x     Document Type: Article

References (23)

1. Earnshaw SA, Cawte SA, Worley A, Hosking DJ. Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. Osteoporos Int 1998 8 : 53 60.
2. Kanterewicz E, Yanez A, Perez-Pons A, Codony I, Del Rio L, Diez-Perez A. Association between Colles' fracture and low bone mass: age-based differences in postmenopausal women. Osteoporos Int 2002 13 : 824 8.
3. Astrand J, Thorngren KG, Tagil M. One fracture is enough Acta Orthopaedica 2006 77 : 3 8.
4. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003 14 : 1028 34.
5. Beringer TR, Finch M, McA Taggart H et al. A study of bone mineral density in women with forearm fracture in Northern Ireland. Osteoporos Int 2005 16 : 430 4.
6. Sosa M, Saavedra P, del Pino-Montes J et al., GIUMO Study Group. Postmenopausal women with colles' fracture have lower values of bone mineral density than controls as measured by quantitative ultrasound and densitometry. J Clin Densitom 2005 8 : 430 5.
7. Looker AC, Johnston CC Jr., Wahner HW et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995 10 : 796 802.
8. Holt G, Khaw KT, Reid DM et al. Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry. Br J Radiol 2002 75 : 736 42.
9. Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 2000 27 : 585 90.
10. Davie MWJ. Fractures at specific sites indicate low bone mineral density at lumbar spine and femoral neck in women. J Orthop Rheumatol 1996 9 : 41 5.
11. Black DM, Cummings SR, Karpf DB et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996 348 : 1535 41.
12. Evans SF, Davie MW. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages. Clin Endocrinol (Oxf) 1996 44 : 79 84.
13. Siegel S. Non Parametric Statistics. New York : McGraw Hill, 1956.
14. Kanis JA, Melton LJ 3rd., Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994 9 : 1137 41.
15. National Institute for Clinical Excellence (NICE). TA87 Bisphosphonates (alendronate, etidronate, risedronate), Selective Oestrogen Receptor Modulators (raloxifene) and Parathyroid Hormone (teriparatide) for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women. London : NICE, 2005.
16. Rossouw JE, Anderson GL, Prentice RL et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002 288 : 321 33.
17. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001 12 : 989 95.
18. Cummings SR, Black DM, Thompson DE et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998 280 : 2077 82.
19. Reginster JY, Seeman E, De Vernejoul MC et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab 2005 90 : 2816 22.
20. McClung MR, Geusens P, Miller PD et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001 344 : 333 40.
21. Porthouse J, Birks YF, Torgerson DJ, Cockayne S, Puffer S, Watt I. Risk factors for fracture in a UK population: a prospective cohort study. QJM 2004 97 : 569 74.
22. Silman AJ. Risk factors for Colles' fracture in men and women: results from the European Prospective Osteoporosis Study. Osteoporos Int 2003 14 : 213 8.
23. Schousboe JT, Fink HA, Taylor BC et al. Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study. J Bone Miner Res 2005 20 : 100 6.